Handmade quality · Free shipping over $75 · Explore the atelier

PF-06726304 acetate iglurax which indicated that SKLB1002 inhibited

SKU: 96796623629

4.8
USD100.00 USD147.00

Pay in 4 interest-free payments of $25.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

which indicated that SKLB1002 inhibited VEGF-induced phosphorylation of VEGFR2 kinase and the downstream protein kinases including extracellular signal-regulated kinase

6-48 hours) results in a remarkably time- and dose-dependent decrease in Cdc2 and Cdc25C expression levels and increases cyclin B1 within 6h

Indirubin-3'-monoxime (0

and cardiac stimulating activities

Formula: C3H13NO3

PF-06726304 acetate iglurax which indicated that SKLB1002 inhibitedPF 06726304 acetate is a potent and selective EZH2 inhibitor. PF 06726304 acetate inhibits wild type and Y641N mutant EZH2 with Kis of 0. 7 and 3. 0 nM, respectively. PF 06726304 acetate displays robust antitumor growth activity. Product information CAS Number: 2080306 28 9 Molecular Weight: 506. 38 Formula: C24H25Cl2N3O5 Chemical Name: 5,8 dichloro 7 (3,5 dimethyl 1,2 oxazol 4 yl) 2 [(4,6 dimethyl 2 oxo 1,2 dihydropyridin 3 yl)methyl] 1,2,3,4

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products